Login / Signup
Reply to "Usefulness of Plasma Amyloid as Prescreener of the Earliest Alzheimer Pathological Changes Depends on the Study Population".
Inge M W Verberk
Charlotte E Teunissen
Wiesje M Van der Flier
Published in:
Annals of neurology (2019)
Keyphrases
</>
cognitive decline